These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8933159)

  • 1. Macrophages in multiple sclerosis.
    Brück W; Sommermeier N; Bergmann M; Zettl U; Goebel HH; Kretzschmar HA; Lassmann H
    Immunobiology; 1996 Oct; 195(4-5):588-600. PubMed ID: 8933159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte/macrophage differentiation in early multiple sclerosis lesions.
    Brück W; Porada P; Poser S; Rieckmann P; Hanefeld F; Kretzschmar HA; Lassmann H
    Ann Neurol; 1995 Nov; 38(5):788-96. PubMed ID: 7486871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
    Henderson AP; Barnett MH; Parratt JD; Prineas JW
    Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions.
    Werner K; Bitsch A; Bunkowski S; Hemmerlein B; Brück W
    Glia; 2002 Oct; 40(1):121-9. PubMed ID: 12237849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendrocytes in the early course of multiple sclerosis.
    Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
    Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
    Storch MK; Piddlesden S; Haltia M; Iivanainen M; Morgan P; Lassmann H
    Ann Neurol; 1998 Apr; 43(4):465-71. PubMed ID: 9546327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
    Koning N; Bö L; Hoek RM; Huitinga I
    Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
    Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
    Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte/macrophage differentiation in dermatomyositis and polymyositis.
    Rostasy KM; Piepkorn M; Goebel HH; Menck S; Hanefeld F; Schulz-Schaeffer WJ
    Muscle Nerve; 2004 Aug; 30(2):225-30. PubMed ID: 15266639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia-derived macrophages in early multiple sclerosis plaques.
    Li H; Cuzner ML; Newcombe J
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):207-15. PubMed ID: 8804022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
    Brück W; Popescu B; Lucchinetti CF; Markovic-Plese S; Gold R; Thal DR; Metz I
    Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis: a protective or a pathogenic role for heat shock protein 60 in the central nervous system?
    Raine CS; Wu E; Ivanyi J; Katz D; Brosnan CF
    Lab Invest; 1996 Jul; 75(1):109-23. PubMed ID: 8683935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some aspects of histopathology in multiple sclerosis].
    Kuhlmann T; Brück W
    Rev Neurol; 2000 Jun 16-30; 30(12):1208-12. PubMed ID: 10935252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination.
    Bajramović JJ; Plomp AC; Goes Av; Koevoets C; Newcombe J; Cuzner ML; van Noort JM
    J Immunol; 2000 Apr; 164(8):4359-66. PubMed ID: 10754336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S
    Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.
    Bitsch A; Schuchardt J; Bunkowski S; Kuhlmann T; Brück W
    Brain; 2000 Jun; 123 ( Pt 6)():1174-83. PubMed ID: 10825356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis.
    Vercellino M; Grifoni S; Romagnolo A; Masera S; Mattioda A; Trebini C; Chiavazza C; Caligiana L; Capello E; Mancardi GL; Giobbe D; Mutani R; Giordana MT; Cavalla P
    Mult Scler; 2011 Oct; 17(10):1194-201. PubMed ID: 21613335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
    Kira J
    J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive hippocampal demyelination in multiple sclerosis.
    Geurts JJ; Bö L; Roosendaal SD; Hazes T; Daniëls R; Barkhof F; Witter MP; Huitinga I; van der Valk P
    J Neuropathol Exp Neurol; 2007 Sep; 66(9):819-27. PubMed ID: 17805012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.